Toxicological and Pharmacological effect of Khadirarista in animal model

Authors

  • Md. Mamun Al-Amin Department of Pharmacy, North South University
  • Shahabuddin Kabir Choudhuri Jahangirnagar University
  • Biplab Kumar Das Department of Pharmacy, North South University
  • J.M.A. Hannan Department of Pharmacy, North South University

Keywords:

Khadirarista (KDR), Biochemical Study, Toxicology

Abstract

The objective of this study is to investigate the toxicological and pharmacological aspects of the popular ayurvedic preparation Khadirarista (KDR). Khadirarista was administered orally to male albino rat. After 46 days of treatment period animals were fasted for 18 hours after the last administration. Biochemical studies including; total protein, serum albumin, blood urea nitrogen, bilirubin, creatinine, aspartate aminotransferase, alanine aminotransferase & alkaline phosphatase were conducted. Triglyceride and Creatinine levels were significantly (p=0.001) decreased in the KDR group than the corresponding control group. Bilirubin, Urea, sGPT, sGOT, ALT contents were also significantly (p=0.001) decreased in KDR group. Lowering of Triglyceride is particularly beneficial in the condition where triglyceride is a burden. Decreased level of liver enzymes (sGPT, sGOT and ALP) and bilirubin content might be caused by KDR induced poor liver function. Further studies are needed to be conducted to reach a concrete decision about its application in human.

Keywords: Khadirarista (KDR), biochemical study, toxicology

Downloads

Published

2013-09-03

Issue

Vol. 2 No. 2 (2013)

Section

Research/Review Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.